1. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023) Authors: Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamo... Journal: European journal of cancer Issue: Volume 180(2023) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy. (March 2021) Authors: Bang, Kyunghye; Cheon, Jaekyung; Jeong, Jae Ho; Im, Hyeon-Su; Kim, Kyu-pyo; Ryoo, Baek-Yeol; Yoo, Changhoon Journal: Therapeutic advances in medical oncology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to "Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyˮ [Eur J Canc 144 (2021) 341–350]. (May 2021) Authors: Jeong, Jae Ho; Kim, Jeong Eun; Ahn, Jin-Hee; Jung, Kyung Hae; Koh, Su-Jin; Cheon, Jaekyung; Sohn, Joohyuk; Kim, Gun Min; Lee, Keun Seok; Sim, Sung Hoon; Park, In Hae; Kim, Sung-Bae Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway. (1st January 2021) Authors: Kim, Jeong Hun; Lee, Won Suk; Lee, Hye Jin; Yang, Hannah; Lee, Seung Joon; Kong, So Jung; Je, Soyeon; Yang, Hyun-Jin; Jung, Jongsun; Cheon, Jaekyung; Kang, Beodeul; Chon, Hong Jae; Kim, Chan Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma. (29th November 2021) Authors: Cheon, Jaekyung; Yoo, Changhoon; Hong, Jung Yong; Kim, Han Sang; Lee, Dae‐Won; Lee, Myung Ah; Kim, Jin Won; Kim, Ilhwan; Oh, Sang‐Bo; Hwang, Jun‐Eul; Chon, Hong Jae; Lim, Ho Yeong Journal: Liver international Issue: Volume 42:Number 3(2022) Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis. (May 2020) Authors: Chae, Heejung; Jeong, Hyehyun; Cheon, Jaekyung; Chon, Hong Jae; Ryu, Hyewon; Kim, Il-Hwan; Kang, Myoung Joo; Jeong, Jae Ho; Ryoo, Baek-Yeol; Kim, Kyu-pyo; Yoo, Changhoon Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor‐positive, HER2‐negative metastatic breast cancer. Issue 4 (7th May 2021) Authors: Jeong, Hyehyun; Jeong, Jae Ho; Kim, Jeong Eun; Ahn, Jin‐Hee; Jung, Kyung Hae; Koh, Su‐Jin; Cheon, Jaekyung; Sohn, Joohyuk; Kim, Gun Min; Lee, Keun Seok; Sim, Sung Hoon; Park, In Hae; Kim, Sung‐Bae Journal: International journal of cancer Issue: Volume 149:Issue 4(2021) Page Start: 917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO study. (February 2021) Authors: Jeong, Jae Ho; Kim, Jeong Eun; Ahn, Jin-Hee; Jung, Kyung Hae; Koh, Su-Jin; Cheon, Jaekyung; Sohn, Joohyuk; Kim, Gun Min; Lee, Keun Seok; Sim, Sung Hoon; Park, In Hae; Kim, Sung-Bae Journal: European journal of cancer Issue: Volume 144(2021) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study. Issue 11 (November 2021) Authors: Yoo, Changhoon; Kim, Kyu-pyo; Jeong, Jae Ho; Kim, Ilhwan; Kang, Myoung Joo; Cheon, Jaekyung; Kang, Byung Woog; Ryu, Hyewon; Lee, Ji Sung; Kim, Kyung Won; Abou-Alfa, Ghassan K; Ryoo, Baek-Yeol Journal: Lancet oncology Issue: Volume 22:Issue 11(2021) Page Start: 1560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment. (23rd August 2022) Authors: Chon, Young Eun; Cheon, Jaekyung; Kim, Hyeyeong; Kang, Beodeul; Ha, Yeonjung; Kim, Do young; Hwang, Seong Gyu; Chon, Hong Jae; Kim, Beom Kyung Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 2731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗